न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

apotex nz ltd - cilazapril monohydrate 1.0425mg equivalent to 1 mg cilazapril - film coated tablet - 1 mg - active: cilazapril monohydrate 1.0425mg equivalent to 1 mg cilazapril excipient: hyprolose hypromellose iron oxide yellow macrogol 8000 maize starch microcrystalline cellulose purified water sodium stearyl fumarate titanium dioxide - apo-cilazapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - cilazapril monohydrate 1.043mg equivalent to cilazapril 1 mg;   - tablet - 1 mg - active: cilazapril monohydrate 1.043mg equivalent to cilazapril 1 mg   excipient: colloidal silicon dioxide crospovidone lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow 85f92084 purified water - cilazapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension. cilazapril is also indicated in the treatment of congestive heart failure as an adjunctive therapy with digitalis and/or diuretics.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - cilazapril monohydrate 2.608mg equivalent to cilazapril 2.5 mg;   - tablet - 2.5 mg - active: cilazapril monohydrate 2.608mg equivalent to cilazapril 2.5 mg   excipient: colloidal silicon dioxide crospovidone lactose monohydrate magnesium stearate microcrystalline cellulose opadry pink 85f14364 purified water - cilazapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension. cilazapril is also indicated in the treatment of congestive heart failure as an adjunctive therapy with digitalis and/or diuretics.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - cilazapril monohydrate 5.215mg equivalent to cilazapril 5 mg;   - tablet - 5 mg - active: cilazapril monohydrate 5.215mg equivalent to cilazapril 5 mg   excipient: colloidal silicon dioxide crospovidone lactose monohydrate magnesium stearate microcrystalline cellulose opadry brown 85f16874 purified water - cilazapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension. cilazapril is also indicated in the treatment of congestive heart failure as an adjunctive therapy with digitalis and/or diuretics.

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - benazepril hydrochloride (unii: n1sn99t69t) (benazeprilat - unii:jrm708l703) - benazepril hydrochloride (hcl) tablets, usp are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs.  control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - benazepril hydrochloride (unii: n1sn99t69t) (benazeprilat - unii:jrm708l703) - benazepril hcl tablets, usp are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs.  control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a va

कनाडा - अंग्रेज़ी - Health Canada

teva canada limited - cilazapril (cilazapril monohydrate); hydrochlorothiazide - tablet - 5mg; 12.5mg - cilazapril (cilazapril monohydrate) 5mg; hydrochlorothiazide 12.5mg - angiotensin-converting enzyme inhibitors

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - benazepril hydrochloride (unii: n1sn99t69t) (benazeprilat - unii:jrm708l703) - benazepril hydrochloride tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

remedyrepack inc. - benazepril hydrochloride (unii: n1sn99t69t) (benazeprilat - unii:jrm708l703) - benazepril hydrochloride tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

direct_rx - benazepril hydrochloride (unii: n1sn99t69t) (benazeprilat - unii:jrm708l703) - benazepril hydrochloride tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from